NUCLEOLIN and Crohn disease: siRNA silencing of NCL or HNRNPA1, alone or together, increased CD39 mRNA levels and MFI in Treg (Fig. 6c) and Th17 cells (Fig. 6d) of Crohn’s disease patients.